Explore more publications!
Healthy Living South Dakota
Got News to Share?

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 19, 2025

Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Parma in Ohio, Expanding its Statewide Retail Footprint
September 19, 2025

Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Parma in Ohio, Expanding its Statewide Retail Footprint

Indeterminate GlobeNewswire
neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
September 19, 2025

neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

Indeterminate GlobeNewswire
Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETOL® in Japan for the Treatment of Hypercholesterolemia
September 19, 2025

Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETOL® in Japan for the Treatment of Hypercholesterolemia

Indeterminate GlobeNewswire
Iterum Therapeutics Provides Business Update
September 19, 2025

Iterum Therapeutics Provides Business Update

Indeterminate GlobeNewswire
Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025
September 19, 2025

Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025

Indeterminate GlobeNewswire
Vaxart Announces Withdrawal of Reverse Stock Split Proposal
September 19, 2025

Vaxart Announces Withdrawal of Reverse Stock Split Proposal

Indeterminate GlobeNewswire
Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum
September 19, 2025

Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum

Indeterminate GlobeNewswire
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC
September 19, 2025

Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC

Indeterminate GlobeNewswire
Bylvay® (odévixibat) approuvé au Japon pour le traitement d’une maladie rare du foie (CIFP)
September 19, 2025

Bylvay® (odévixibat) approuvé au Japon pour le traitement d’une maladie rare du foie (CIFP)

Indeterminate GlobeNewswire
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
September 19, 2025

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars

Indeterminate GlobeNewswire
SAB BIO Highlights Data in Multiple Presentations at EASD
September 19, 2025

SAB BIO Highlights Data in Multiple Presentations at EASD

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Expands Spider Silk Manufacturing with Pursuit of Additional Rearing Center
September 19, 2025

Kraig Biocraft Laboratories Expands Spider Silk Manufacturing with Pursuit of Additional Rearing Center

Indeterminate GlobeNewswire
Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks
September 19, 2025

Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks

Indeterminate GlobeNewswire
Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
September 19, 2025

Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

Indeterminate GlobeNewswire
Skye Presents Phase 1b Data for its Peripheral CB1-inhibiting Antibody, Nimacimab, at European Association for the Study of Diabetes (EASD) Annual Meeting
September 19, 2025

Skye Presents Phase 1b Data for its Peripheral CB1-inhibiting Antibody, Nimacimab, at European Association for the Study of Diabetes (EASD) Annual Meeting

Indeterminate GlobeNewswire
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share
September 19, 2025

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share

Indeterminate GlobeNewswire
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
September 19, 2025

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders

Indeterminate GlobeNewswire
Jasper Therapeutics Announces Pricing of $30 Million Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
September 19, 2025

Jasper Therapeutics Announces Pricing of $30 Million Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants

Indeterminate GlobeNewswire
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering
September 19, 2025

Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions